3,266
Views
10
CrossRef citations to date
0
Altmetric
Review

Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability

, , , , , & show all
Pages 609-620 | Received 25 Oct 2018, Accepted 26 Dec 2018, Published online: 04 Mar 2019

References

  • Shanmugam MK, Dai X, Kumar AP, et al. Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. Biochem Pharmacol. 2013;85:1579–1587.
  • Kazmi I, Afzal M, Gupta G, et al. Antiepileptic potential of ursolic acid stearoyl glucoside by GABA receptor stimulation. CNS Neurosci Ther. 2012;18:799–800.
  • Li WG, Zhao XH, Sun XL, et al. Evaluation of antioxidant ability in vitro and bioavailability of trans-cinnamic acid nanoparticle by liquid antisolvent precipitate. J Nanomater. 2016;2016:9518362.
  • Wang QQ, Zhao TT, Liu YP, et al. An evaluation of anti-tumor effect and toxicity of PEGylated ursolic acid liposomes. J Nanopart Res. 2016;18:155–167.
  • Shanmugam MK, Nguyen AH, Kumar AP, et al. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer. Cancer Lett. 2012;320:158–170.
  • Xiong B, Lei ZY, Chen H. Research progress of ursolic acid pharmacology. Foreign Med Sci Sect Pharmacy. 2004;31:133–136.
  • Gao Y, Li Z, Xie X, et al. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation. Eur J Pharm Sci. 2015;70:55–63.
  • Qiu L, Zhao XH, Zu YG, et al. Preparation, characterization, and dissolution characteristics of ursolic acid nanoparticles prepared by emulsion solvent evaporation method. Chin Tradit Herbal Drugs. 2018;49:2387–2393.
  • Ou XX, Wang ZM, Feng L. Preparation and bioavailability of ursolic acid self-microemulsion. Chin J ETMF. 2012;18:36–39.
  • Qi N, Liu G, Liao Y, et al. Preparation and in vivo release behavior investigation of ursolic acid liposome. Chin J ETMF. 2013;19:28–31.
  • Eloy JO, Saraiva J, Albuquerque S, et al. Preparation, characterization and evaluation on the in vivo trypanocidal activity of ursolic acid-loaded solid dispersion with poloxamer 407 and sodium caprate. Braz J Pharm Sci. 2015;51:101–109.
  • Zong W, Zhang H, Yuan WL, et al. Study on the preparation of ursolic acid-β-cyclodextrin inclusion complex by ultrasonic wave and its characteristic. China Acad J Electronic. 2011;32:237–239.
  • Soukoulis C, Torsten B. A comprehensive overview on the micro and nano technological encapsulation advances for enhancing the chemical stability and bioavailability of carotenoids. Crit Rev Food Sci Nutr. 2018;58:1–36.
  • Ain-Ai A, Gupta PK. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. Int J Pharm. 2008;351:282–288.
  • Gao L, Zhang DR, Chen MH. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res. 2008;10:845–862.
  • Yang L, Sun Z, Zu Y, et al. Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process. Food Chem. 2012;132:319–325.
  • Pi JX, Liu ZD, Wang H, et al. Ursolic acid nanocrystals for dissolution rate and bioavailability enhancement: influence of different particle size. CDD. 2016;13:1358–1366.
  • Huang H, Zhang BF. Determination of ursolic acid and oleanolic acid in different varieties of kuding tea. China Acad J Electronic Publishing House. 2012;40:243–245.
  • Zhao XH, Deng YP, Zhang Y, et al. Silymarin nanoparticles through emulsion solvent evaporation method for oral delivery with high antioxidant activities, bioavailability, and absorption in the liver. RSC Adv. 2016;6:93137–93146.
  • Hu J, Ng WK, Dong Y, et al. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int J Pharm. 2011;404:198–204.
  • Li Y, Zhao X, Zu Y, et al. Preparation and characterization of micronized ellagic acid using antisolvent precipitation for oral delivery. Int J Pharm. 2015;486:207–216.
  • He W, Lu Y, Qi J, et al. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs. Int J Pharm. 2013;441:269–278.
  • Zhao X, Wang W, Zu Y, et al. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation. Drug Deliv. 2014;21:467–479.
  • Wolfe KL, Kang XM, He XJ, et al. Cellular antioxidant activity of common fruits. J Agric Food Chem. 2008;56:8418–8426.
  • Wolfe KL, Liu RH. Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. J Agric Food Chem. 2007;55:8896–8907.
  • Ahuja BK, Jena SK, Paidi SK, et al. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Int J Pharm. 2015;478:540–552.
  • Collins JM, Despa F, Lee RC. Structural and functional recovery of electropermeabilized skeletal muscle in-vivo after treatment with surfactant poloxamer 188. Biochim Biophys Acta. 2007;1768:1238–1246.
  • Raymond CR, Paul JS, Marian EQ. Handbook of pharmaceutical excipients. 6th ed. Pharmaceutical Press; 2009.
  • Zu Y, Meng L, Zhao X, et al. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. Int J Nanomed. 2013;8:1207–1222.
  • Zu YG, Sun W, Zhao XH, et al. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation. Eur J Pharm Sci. 2014;53:109–117.
  • Zu YG, Yu XY, Zhao XH, et al. Nanocrystallization of the pharmaceutically active agent Genipin by an emulsion solvent evaporation method. Int J Nanomed. 2014;2014:1–13.
  • Zhang Y, Li Y, Zhao XH, et al. Preparation, characterization and bioavailability of oral puerarin nanoparticles by emulsion solvent evaporation method. RSC Adv. 2016;6:889–901.
  • Jin IJ, Ko YI, Kim YM, et al. Solubilization of oleanolic acid and ursolic acid by cosolvency. Arch Pharm Res. 1997;20:169–175.
  • Ge ZQ, Du XY, Huang XN, et al. Enhanced oral bioavailability of ursolic acid nanoparticles via antisolvent precipitation with TPGS1000 as a stabilizer. J Drug Deliv Sci Technol. 2015;29:210–217.
  • Dong Y, Ng WK, Hu J, et al. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs. Int J Pharm. 2010;386:256–261.
  • Mosharraf M, Nystrom C. Apparent solubility of drugs in partially crystalline systems. Drug Dev Ind Pharm. 2003;29:603–622.
  • Kim S, Ng WK, Dong Y, et al. Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation. J Food Eng. 2012;108:37–42.
  • Emilli A, Osmar dRAJ, Isis SdA, Najeh Mk, Rubiana MM. Poly(lactic acid) nanoparticles loaded with ursolic acid: characterization and in vitro evaluation of radical scavenging activity and cytotoxicity. Mater Sci Eng C. 2017;71:156–166.
  • Hecq J, Deleers M, Fanara D, et al. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm. 2005;299:167–177.
  • Brough C, Williams RO. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. Int J Pharm. 2013;453:157–166.